Today's events for June 21
The Post and Courier· 6 days agoSurvival Island will be held at 5:30 p.m. Thursday, July 14, at the Aiken County Public Library, 314 Chesterfield St. S.W. Children ages 6-12 can find...
Half of UK adults wouldn’t be able to identify bowel cancer from their poo, survey finds
The Independent via Yahoo News· 2 days ago“If it is caught early, treatment can cure bowel cancer and stop it coming back. However, survival...
'Everyone's stressed': Fayetteville nonprofit connects food insecurity and gun violence
WTVD-TV 11 Raleigh-Durham· 4 days agoWith a vision in mind, Tony Brown walked the trail on Wednesday that he sees children taking in the...
Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for...
WTVY Dothan· 2 days agoDaewoong announced that the U.S. Food and Drug Administration (FDA) had approved the IND for the phase 2 clinical trial of DWN12088, a PRS (Prolyl-tRNA Synthetase) inhibitor ...
How FDA Is Working to Improve Oncology Drug Development
Medscape· 2 days agoThe US Food and Drug Administration (FDA) is trying to improve how oncology drugs arrive in the...
Brazil's Indigenous activists on their fight for the planet's survival
Vice· 6 days agoOver ten days in April, members of Indigenous communities from across Brazil descended upon...
EARLY YEARS: Survival tips for long family road trips this summer
WDBJ 7 Roanoke· 2 days agoAre we there yet? Parents, most of us have heard that question from our kids on those long family...
Curbing hunger: Students build inventive outdoor food pantry | Cornell Chronicle
Cornell News Service· 4 days agoIn a spring semester class, seven Cornell engineering undergraduates planned and built an outdoor ...
'A daily burden of survival': Deadly Afghanistan earthquake piles more agony onto the country's...
Business Insider· 3 days agoA Kabul-based aid worker told Insider that "it's all hands on deck" as organizations manage bad...
U.S. FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi® for Relapsed or Refractory...
Benzinga· 2 days agoIn the pivotal Phase 3 TRANSFORM trial, single infusion of Breyanzi significantly outperformed the nearly 30-year standard of care with median event-free survival of 10.1 months vs. 2.3 months and a well-established